Advertisement

American Journal of Clinical Dermatology

, Volume 16, Issue 6, pp 501–531 | Cite as

The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review

  • Anna Sokolova
  • Andrew LeeEmail author
  • Saxon D Smith
Review Article

Abstract

Narrow-band ultraviolet B (NBUVB) phototherapy is an important treatment modality in dermatology. The most common dermatological indications for NBUVB include psoriasis, atopic dermatitis and vitiligo; however, it has been found to be an effective and well-tolerated treatment option in various other dermatoses. The efficacy of NBUVB phototherapy compares favorably with other available photo(chemo)therapy options and its efficacy is further augmented by a number of topical and systemic adjuncts. The long-term safety of NBUVB phototherapy remains to be fully elucidated; however, available data now suggest that it is safe and well-tolerated. The objective of this review was to summarize the current understanding of the safety and efficacy of NBUVB phototherapy in dermatology.

Keywords

Atopic Dermatitis Vitiligo Plaque Psoriasis Mycosis Fungoides Pimecrolimus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with Ethical Standards

Funding

No funding was received for the preparation of this review.

Conflict of interest

Anna Sokolova, Andrew Lee and Saxon Smith have no conflicts of interest.

References

  1. 1.
    van Weelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119(1):11–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62(1):114–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Taieb A, Alomar A, Bohm M, Dell’anna ML, De Pase A, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5–19.PubMedCrossRefGoogle Scholar
  5. 5.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A,Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70(2):223 e1-17; quiz 240-2.Google Scholar
  6. 6.
    Oxford Center for Evidence-Based Medicine-Levels of Evidence (March 2009). http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed 24 Aug 2014.
  7. 7.
    Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 2013;14(2):87–109.PubMedCrossRefGoogle Scholar
  8. 8.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, et al. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):11–21.PubMedCrossRefGoogle Scholar
  9. 9.
    Pavlovsky M, Baum S, Shpiro D, Pavlovsky L, Pavlotsky F. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? J Eur Acad Dermatol Venereol. 2011;25(6):727–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Jury CS, McHenry P, Burden AD, Lever R, Bilsland D. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006;31(2):196–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Jain VK, Bansal A, Aggarwal K, Jain K. Enhanced response of childhood psoriasis to narrow-band UV-B phototherapy with preirradiation use of mineral oil. Pediatr Dermatol. 2008;25(5):559–64.PubMedCrossRefGoogle Scholar
  12. 12.
    Penven K, Leroy D, Verneuil L, Faguer K, Dompmartin A. Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis. Photodermatol Photoimmunol Photomed. 2005;21(3):138–41.PubMedCrossRefGoogle Scholar
  13. 13.
    George SA, Bilsland DJ, Wainwright NJ, Ferguson J. Failure of coconut oil to accelerate psoriasis clearance in narrow-band UVB phototherapy or photochemotherapy. Br J Dermatol. 1993;128(3):301–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Martin-Ezquerra G, Sanchez-Regana M, Umbert-Millet P. Optimization of narrow-band uvb with a 5 % oleic acid cream in the treatment of psoriasis. J Drugs Dermatol. 2007;6(3):290–2.PubMedGoogle Scholar
  15. 15.
    Abdallah MA, El-Khateeb EA, Abdel-Rahman SH. The influence of psoriatic plaques pretreatment with crude coal tar vs. petrolatum on the efficacy of narrow-band ultraviolet B: a half-vs.-half intra-individual double-blinded comparative study. Photodermatol Photoimmunol Photomed. 2011;27(5):226–30.PubMedCrossRefGoogle Scholar
  16. 16.
    Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol. 2009; 8(4):351–7.PubMedGoogle Scholar
  17. 17.
    Kerscher M, Volkenandt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet. 1993;342(8876):923.PubMedCrossRefGoogle Scholar
  18. 18.
    Brands S, Brakman M, Bos JD, de Rie MA. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol. 1999;41(6):991–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Rim JH, Choe YB, Youn JI. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients. Photodermatol Photoimmunol Photomed. 2002;18(3):131–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Woo WK, McKenna KE. Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. Br J Dermatol. 2003;149(1):146–50.PubMedCrossRefGoogle Scholar
  21. 21.
    Hofmann UB, Eggert AA, Brocker EB, Goebeler M. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. Br J Dermatol. 2003;148(4):779–83.PubMedCrossRefGoogle Scholar
  22. 22.
    Noborio R, Kobayashi K, Shintani Y, Morita A. Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed. 2006;22(5):262–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Takekoshi T, Asahina A, Komine M, Tamaki K. Treatment of psoriasis vulgaris with narrow-band UVB and topical Maxacalcitol. Acta Derm Venereol. 2006;86(4):375–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Brazzelli V, Barbagallo T, Prestinari F, Rona C, De Silvestri A, et al. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: “right-left intra-individual pre/post comparison design”. Int J Immunopathol Pharmacol. 2005;18(4):755–60.PubMedGoogle Scholar
  25. 25.
    Amornpinyokeit N, Asawanonda P. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis. Photodermatol Photoimmunol Photomed. 2006;22(6):285–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Ehsani AH, Ghaninejad H, Kiani A, Daneshpazhooh M, Hosseini SH, et al. Comparison of topical 8-methoxypsoralen and narrowband ultraviolet B with narrowband ultraviolet B alone in treatment-resistant sites in plaque-type psoriasis: a placebo-controlled study. Photodermatol Photoimmunol Photomed. 2011;27(6):294–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Jain VK, Jangra S, Aggarwal K. Comparative efficacy of narrow-band ultraviolet B phototherapy alone and its combination with topical 8-methoxypsoralen in psoriasis. Indian J Dermatol Venereol Leprol. 2010;76(6):666–70.PubMedCrossRefGoogle Scholar
  28. 28.
    Asawanonda P, Amornpinyokeit N, Nimnuan C. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis. J Eur Acad Dermatol Venereol. 2008;22(1):50–5.PubMedGoogle Scholar
  29. 29.
    Seckin D, Usta I, Yazici Z, Senol A. Topical 8-methoxypsoralen increases the efficacy of narrowband ultraviolet B in psoriasis. Photodermatol Photoimmunol Photomed. 2009;25(5):237–41.PubMedCrossRefGoogle Scholar
  30. 30.
    Calzavara-Pinton P. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination. J Am Acad Dermatol. 1998;38(5 Pt 1):687–90.PubMedCrossRefGoogle Scholar
  31. 31.
    Mahajan R, Kaur I, Kanwar AJ. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis: a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol. 2010;24(5):595–600.PubMedCrossRefGoogle Scholar
  32. 32.
    Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. J Am Acad Dermatol. 2006;54(6):1013–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Kampitak T, Asawanonda P. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study. J Med Assoc Thai. 2006;89(Suppl 3):S20–4.PubMedGoogle Scholar
  34. 34.
    Ozdemir M, Engin B, Baysal I, Mevlitoglu I. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis. Acta Derm Venereol. 2008;88(6):589–93.PubMedGoogle Scholar
  35. 35.
    Mortazavi H, Khezri S, Hosseini H, Khezri F, Vasigh M. A single blind randomized clinical study: the efficacy of isotretinoin plus narrow band ultraviolet B in the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed. 2011;27(3):159–61.PubMedCrossRefGoogle Scholar
  36. 36.
    Franchi C, Cainelli G, Frigerio E, Garutti C, Altomare GF. Association of cyclosporine and 311 nM UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach. Int J Immunopathol Pharmacol. 2004;17(3):401–6.PubMedGoogle Scholar
  37. 37.
    Colombo MD, Cassano N, Bellia G, Vena GA. Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches. Sci World J. 2013;2013:805705.CrossRefGoogle Scholar
  38. 38.
    Kircik L, Bagel J, Korman N, Menter A, Elmets CA, et al. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol. 2008;7(3):245–53.PubMedGoogle Scholar
  39. 39.
    Wolf P, Hofer A, Legat FJ, Bretterklieber A, Weger W, et al. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept. Br J Dermatol. 2009;160(1):186–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, et al. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks. Br J Dermatol. 2011;164(6):1383–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Lynde CW, Gupta AK, Guenther L, Poulin Y, Levesque A, et al. A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept. J Dermatolog Treat. 2012;23(4):261–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Lui H, Gulliver W, Tan J, Hong CH, Hull P, et al. A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response. J Drugs Dermatol. 2012;11(8):929–37.PubMedGoogle Scholar
  43. 43.
    Ortonne JP, Khemis A, Koo JY, Choi J. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2005;19(5):556–63.PubMedCrossRefGoogle Scholar
  44. 44.
    Legat FJ, Hofer A, Wackernagel A, Salmhofer W, Quehenberger F, et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol. 2007;143(8):1016–22.PubMedCrossRefGoogle Scholar
  45. 45.
    Bagel J. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis. J Drugs Dermatol. 2011;10(4):366–71.PubMedGoogle Scholar
  46. 46.
    Wolf P, Hofer A, Weger W, Posch-Fabian T, Gruber-Wackernagel A, et al. 311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients. Photodermatol Photoimmunol Photomed. 2011;27(4):186–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Wolf P, Weger W, Legat FJ, Posch-Fabian T, Gruber-Wackernagel A, et al. Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial. Br J Dermatol. 2012;166(1):147–53.PubMedCrossRefGoogle Scholar
  48. 48.
    Kircik LH, Liu C, Goffe BS. Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy. J Drugs Dermatol. 2008;7(10):947–52.PubMedGoogle Scholar
  49. 49.
    Zane C, Capezzera R, Venturini M, Sala R, Facchinetti E, et al. A short cycle of narrow-band UVB phototherapy in the early phase of long-term efalizumab can provide a quicker remission of moderate and severe psoriasis: a pilot study. Dermatology. 2009;218(4):321–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Park KK, Wu JJ,Koo J. A randomized, ‘head-to-head’ pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients. J Eur Acad Dermatol Venereol. 2013;27(7):899–906.Google Scholar
  51. 51.
    Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, et al. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis. Br J Dermatol. 2013;169(1):130–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Chen X, Yang M, Cheng Y, Liu GJ, Zhang M. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. Cochrane Database Syst Rev. 2013;10:CD009481.PubMedGoogle Scholar
  53. 53.
    Paul C, Gallini A, Archier E, Castela E, Devaux S, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):1–10.PubMedCrossRefGoogle Scholar
  54. 54.
    Hudson-Peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol. 1996;135(2):332.PubMedCrossRefGoogle Scholar
  55. 55.
    Grundmann-Kollmann M, Behrens S, Podda M, Peter RU, Kaufmann R, et al. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol. 1999;40(6 Pt 1):995–7.PubMedCrossRefGoogle Scholar
  56. 56.
    Tintle S, Shemer A, Suarez-Farinas M, Fujita H, Gilleaudeau P, et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. J Allergy Clin Immunol. 2011;128(3):583–93.e1-4.Google Scholar
  57. 57.
    Clayton TH, Clark SM, Turner D, Goulden V. The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy. Clin Exp Dermatol. 2007;32(1):28–33.PubMedGoogle Scholar
  58. 58.
    George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol. 1993;128(1):49–56.PubMedCrossRefGoogle Scholar
  59. 59.
    Brazzelli V, Prestinari F, Chiesa MG, Borroni RG, Ardigo M, et al. Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy. Dermatology. 2002;204(3):252–4.PubMedCrossRefGoogle Scholar
  60. 60.
    Heinlin J, Schiffner-Rohe J, Schiffner R, Einsele-Kramer B, Landthaler M, et al. A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow-band UVB monotherapy for atopic dermatitis. J Eur Acad Dermatol Venereol. 2011;25(7):765–73.PubMedCrossRefGoogle Scholar
  61. 61.
    Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet. 2001;357(9273):2012–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Hjerppe M, Hasan T, Saksala I, Reunala T. Narrow-band UVB treatment in atopic dermatitis. Acta Derm Venereol. 2001;81(6):439–40.PubMedCrossRefGoogle Scholar
  63. 63.
    Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol. 2000;142(1):39–43.PubMedCrossRefGoogle Scholar
  64. 64.
    Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, et al. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol. 2003;139(2):223–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Majoie IM, Oldhoff JM, van Weelden H, Laaper-Ertmann M, Bousema MT, et al. Narrowband ultraviolet B and medium-dose ultraviolet al are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol. 2009;60(1):77–84.PubMedCrossRefGoogle Scholar
  66. 66.
    Gambichler T, Othlinghaus N, Tomi NS, Holland-Letz T, Boms S, et al. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Br J Dermatol. 2009;160(3):652–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997;133(12):1525–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Int J Dermatol. 2005;44(1):57–60.PubMedCrossRefGoogle Scholar
  69. 69.
    Kishan Kumar YH, Rao GR, Gopal KV, Shanti G, Rao KV. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo. Indian J Dermatol Venereol Leprol. 2009;75(2):162–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 2001;44(6):999–1003.PubMedCrossRefGoogle Scholar
  71. 71.
    Anbar TS, Westerhof W, Abdel-Rahman AT, El-Khayyat MA. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol Photoimmunol Photomed. 2006;22(3):157–63.PubMedCrossRefGoogle Scholar
  72. 72.
    Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi MR. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed. 2012;28(3):115–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Natta R, Somsak T, Wisuttida T, Laor L. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol. 2003;49(3):473–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Nicolaidou E, Antoniou C, Stratigos AJ, Stefanaki C, Katsambas AD. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol. 2007;56(2):274–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42(2 Pt 1):245–53.PubMedCrossRefGoogle Scholar
  76. 76.
    Percivalle S, Piccinno R, Caccialanza M, Forti S. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients. Pediatr Dermatol. 2012;29(2):160–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Brazzelli V, Prestinari F, Castello M, Bellani E, Roveda E, et al. Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). Pediatr Dermatol. 2005;22(3):257–61.PubMedCrossRefGoogle Scholar
  78. 78.
    Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30(4):332–6.PubMedCrossRefGoogle Scholar
  79. 79.
    Goktas EO, Aydin F, Senturk N, Canturk MT, Turanli AY. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2006;20(5):553–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Hartmann A, Lurz C, Hamm H, Brocker EB, Hofmann UB. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol. 2005;44(9):736–42.PubMedCrossRefGoogle Scholar
  81. 81.
    Gamil H, Attwa E, Ghonemy S. Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo. Clin Exp Dermatol. 2010;35(8):919–21.PubMedCrossRefGoogle Scholar
  82. 82.
    Arca E, Tastan HB, Erbil AH, Sezer E, Koc E, et al. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol. 2006;33(5):338–43.PubMedCrossRefGoogle Scholar
  83. 83.
    Kullavanijaya P, Lim HW. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2004;20(5):248–51.PubMedCrossRefGoogle Scholar
  84. 84.
    Ada S, Sahin S, Boztepe G, Karaduman A, Kolemen F. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Photodermatol Photoimmunol Photomed. 2005;21(2):79–83.PubMedCrossRefGoogle Scholar
  85. 85.
    Dogra S, Parsad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch Dermatol. 2003;139(3):393.PubMedCrossRefGoogle Scholar
  86. 86.
    Leone G, Pacifico A, Iacovelli P, Paro Vidolin A, Picardo M. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clin Exp Dermatol. 2006;31(2):200–5.PubMedCrossRefGoogle Scholar
  87. 87.
    Nordal EJ, Guleng GE, Ronnevig JR. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1 %) vs. placebo ointment, a randomized right/left double-blind comparative study. J Eur Acad Dermatol Venereol. 2011;25(12):1440–3.PubMedCrossRefGoogle Scholar
  88. 88.
    Majid I. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left–right comparison study. Photodermatol Photoimmunol Photomed. 2010;26(5):230–4.PubMedCrossRefGoogle Scholar
  89. 89.
    Mehrabi D, Pandya AG. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1 % tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch Dermatol. 2006;142(7):927–9.PubMedCrossRefGoogle Scholar
  90. 90.
    Klahan S, Asawanonda P. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study. Clin Exp Dermatol. 2009;34(8):e1029–30.PubMedCrossRefGoogle Scholar
  91. 91.
    Fai D, Cassano N, Vena GA. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J Eur Acad Dermatol Venereol. 2007;21(7):916–20.PubMedCrossRefGoogle Scholar
  92. 92.
    Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatolog Treat. 2009;20(1):14–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Schallreuter KU, Kruger C, Wurfel BA, Panske A, Wood JM. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol. 2008;47(7):743–53.PubMedCrossRefGoogle Scholar
  94. 94.
    Patel DC, Evans AV, Hawk JL. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol. 2002;27(8):641–4.PubMedCrossRefGoogle Scholar
  95. 95.
    Bakis-Petsoglou S, Le Guay JL, Wittal R. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. Br J Dermatol. 2009;161(4):910–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Kostovic K, Pastar Z, Pasic A, Ceovic R. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase. Acta Dermatovenerol Croat. 2007;15(1):10–4.PubMedGoogle Scholar
  97. 97.
    Adauwiyah J, Suraiya HH. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients. Med J Malays. 2010;65(4):297–9.Google Scholar
  98. 98.
    Abd El-Samad Z, Shaaban D. Treatment of localized non-segmental vitiligo with intradermal 5-flurouracil injection combined with narrow-band ultraviolet B: a preliminary study. J Dermatolog Treat. 2012;23(6):443–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Asawanonda P, Klahan SO. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Photomed Laser Surg. 2010;28(5):679–84.PubMedCrossRefGoogle Scholar
  100. 100.
    Majid I. Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo? Indian J Dermatol Venereol Leprol. 2010;76(3):254–8.PubMedCrossRefGoogle Scholar
  101. 101.
    Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol. 2002;82(5):369–72.PubMedCrossRefGoogle Scholar
  102. 102.
    Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol. 2009;49(7):852–5.PubMedCrossRefGoogle Scholar
  103. 103.
    Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatol Venereol. 2007;21(7):942–50.PubMedCrossRefGoogle Scholar
  104. 104.
    Dell’Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, et al. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol. 2007;32(6):631–6.PubMedCrossRefGoogle Scholar
  105. 105.
    Rath N, Kar HK, Sabhnani S. An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo. Indian J Dermatol Venereol Leprol. 2008;74(4):357–60.PubMedCrossRefGoogle Scholar
  106. 106.
    Mofty ME, Zaher H, Esmat S, Youssef R, Shahin Z, et al. PUVA and PUVB in vitiligo: are they equally effective? Photodermatol Photoimmunol Photomed. 2001;17(4):159–63.PubMedCrossRefGoogle Scholar
  107. 107.
    El Mofty M, Mostafa W, Esmat S, Youssef R, Azzam O, et al. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies. Photodermatol Photoimmunol Photomed. 2006;22(1):6–11.PubMedCrossRefGoogle Scholar
  108. 108.
    Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatol. 2013;149(1):68–73.PubMedCrossRefGoogle Scholar
  109. 109.
    Anbar TS, Westerhof W, Abdel-Rahman AT, Ewis AA, El-Khayyat MA. Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left–right comparative study. Photodermatol Photoimmunol Photomed. 2008;24(6):322–9.PubMedCrossRefGoogle Scholar
  110. 110.
    Bayoumi W, Fontas E, Sillard L, Le Duff F, Ortonne JP, et al. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. Br J Dermatol. 2012;166(1):208–11.PubMedCrossRefGoogle Scholar
  111. 111.
    Shin J, Lee JS, Hann SK, Oh SH. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Br J Dermatol. 2012;166(3):658–61.PubMedCrossRefGoogle Scholar
  112. 112.
    van Geel N, Ongenae K, De Mil M, Haeghen YV, Vervaet C, et al. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol. 2004;140(10):1203–8.PubMedGoogle Scholar
  113. 113.
    El-Zawahry BM, Bassiouny DA, Sobhi RM, Abdel-Aziz E, Zaki NS, et al. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2012;28(2):84–90.PubMedCrossRefGoogle Scholar
  114. 114.
    Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Arch Dermatol. 2007;143(5):578–84.PubMedCrossRefGoogle Scholar
  115. 115.
    Parsad D, Kanwar AJ, Kumar B. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2006;20(2):175–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Sapam R, Agrawal S, Dhali TK. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int J Dermatol. 2012;51(9):1107–15.PubMedCrossRefGoogle Scholar
  117. 117.
    Bhatnagar A, Kanwar AJ, Parsad D, De D. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol Venereol. 2007;21(5):638–42.PubMedGoogle Scholar
  118. 118.
    Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, et al. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311–313 nm) in the treatment of vitiligo: a multicentre controlled study. J Eur Acad Dermatol Venereol. 2007;21(7):956–63.PubMedCrossRefGoogle Scholar
  119. 119.
    Hong SB, Park HH, Lee MH. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Korean Med Sci. 2005;20(2):273–8.PubMedCentralPubMedCrossRefGoogle Scholar
  120. 120.
    Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, et al. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol. 2012;26(6):690–5.PubMedCrossRefGoogle Scholar
  121. 121.
    Verhaeghe E, Lodewick E, van Geel N, Lambert J. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial. Dermatology. 2011;223(4):343–8.PubMedCrossRefGoogle Scholar
  122. 122.
    Asawanonda P, Kijluakiat J, Korkij W, Sindhupak W. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study. Acta Derm Venereol. 2008;88(4):376–81.PubMedGoogle Scholar
  123. 123.
    Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol. 1999;135(11):1377–80.PubMedCrossRefGoogle Scholar
  124. 124.
    Clark C, Dawe RS, Evans AT, Lowe G, Ferguson J. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol. 2000;136(6):748–52.PubMedCrossRefGoogle Scholar
  125. 125.
    Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol. 2002;47(2):191–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Ghodsi SZ, Hallaji Z, Balighi K, Safar F, Chams-Davatchi C. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clin Exp Dermatol. 2005;30(4):376–8.PubMedCrossRefGoogle Scholar
  127. 127.
    Boztepe G, Sahin S, Ayhan M, Erkin G, Kilemen F. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol. 2005;53(2):242–6.PubMedCrossRefGoogle Scholar
  128. 128.
    Kural Y, Onsun N, Aygin S, Demirkesen C, Buyukbabani N. Efficacy of narrowband UVB phototherapy in early stage of mycosis fungoides. J Eur Acad Dermatol Venereol. 2006;20(1):104–5.PubMedCrossRefGoogle Scholar
  129. 129.
    Brazzelli V, Antoninetti M, Palazzini S, Prestinari F, Borroni G. Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients. Photodermatol Photoimmunol Photomed. 2007;23(6):229–33.PubMedCrossRefGoogle Scholar
  130. 130.
    Gokdemir G, Barutcuoglu B, Sakiz D, Koslu A. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes. J Eur Acad Dermatol Venereol. 2006;20(7):804–9.PubMedGoogle Scholar
  131. 131.
    Kanokrungsee S, Rajatanavin N, Rutnin S, Vachiramon V. Efficacy of narrowband ultraviolet B twice weekly for hypopigmented mycosis fungoides in Asians. Clin Exp Dermatol. 2012;37(2):149–52.PubMedCrossRefGoogle Scholar
  132. 132.
    Ferahbas A, Utas S, Ulas Y, Kontas O, Karakukcu M, et al. Narrow band UVB treatment for a child with mycosis fungoides. Pediatr Dermatol. 2006;23(3):302–3.PubMedCrossRefGoogle Scholar
  133. 133.
    Kavala M, Zindanci I, Buyukbabani N, Turkoglu Z, Kocaturk E, et al. Treatment of childhood mycosis fungoides with narrow-band phototherapy. Int J Dermatol. 2009;48(2):203–4.PubMedCrossRefGoogle Scholar
  134. 134.
    D’Acunto C, Gurioli C, Neri I. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB. J Dermatol Treat. 2010;21(1):45–8.CrossRefGoogle Scholar
  135. 135.
    Lokitz ML, Wong HK. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides. Photodermatol Photoimmunol Photomed. 2007;23(6):255–7.PubMedCrossRefGoogle Scholar
  136. 136.
    El-Mofty M, El-Darouty M, Salonas M, Bosseila M, Sobeih S, et al. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right–left comparative study. Photodermatol Photoimmunol Photomed. 2005;21(6):281–6.PubMedCrossRefGoogle Scholar
  137. 137.
    Ahmad K, Rogers S, McNicholas PD, Collins P. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study. Acta Derm Venereol. 2007;87(5):413–7.PubMedCrossRefGoogle Scholar
  138. 138.
    Ponte P, Serrao V, Apetato M. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides. J Eur Acad Dermatol Venereol. 2010;24(6):716–21.PubMedCrossRefGoogle Scholar
  139. 139.
    El-Mofty M, Mostafa WZ, Bosseila M, Youssef R, Esmat S, et al. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides. Dermatol Ther. 2010;23(4):428–34.PubMedCrossRefGoogle Scholar
  140. 140.
    Diederen PV, van Weelden H, Sanders CJ, Toonstra J, van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol. 2003;48(2):215–9.PubMedCrossRefGoogle Scholar
  141. 141.
    Pavlotsky F, Barzilai A, Kasem R, Shpiro D, Trau H. UVB in the management of early stage mycosis fungoides. J Eur Acad Dermatol Venereol. 2006;20(5):565–72.PubMedCrossRefGoogle Scholar
  142. 142.
    Wongpraparut C, Setabutra P. Phototherapy for hypopigmented mycosis fungoides in Asians. Photodermatol Photoimmunol Photomed. 2012;28(4):181–6.PubMedCrossRefGoogle Scholar
  143. 143.
    Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol. 2000;143(5):964–8.PubMedCrossRefGoogle Scholar
  144. 144.
    Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol. 2002;41(5):282–3.PubMedCrossRefGoogle Scholar
  145. 145.
    Saricaoglu H, Karadogan SK, Baskan EB, Tunali S. Narrowband UVB therapy in the treatment of lichen planus. Photodermatol Photoimmunol Photomed. 2003;19(5):265–7.PubMedCrossRefGoogle Scholar
  146. 146.
    Wackernagel A, Legat FJ, Hofer A, Quehenberger F, Kerl H, et al. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus. Photodermatol Photoimmunol Photomed. 2007;23(1):15–9.PubMedCrossRefGoogle Scholar
  147. 147.
    Pavlotsky F, Nathansohn N, Kriger G, Shpiro D, Trau H. Ultraviolet-B treatment for cutaneous lichen planus: our experience with 50 patients. Photodermatol Photoimmunol Photomed. 2008;24(2):83–6.PubMedCrossRefGoogle Scholar
  148. 148.
    Gamil H, Nassar A, Saadawi A, El-Qashishi K, Ahmed F. Narrow-band ultraviolet B phototherapy in lichen planus. J Eur Acad Dermatol Venereol. 2009;23(5):589–90.PubMedCrossRefGoogle Scholar
  149. 149.
    Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol. 1995;132(6):956–63.PubMedCrossRefGoogle Scholar
  150. 150.
    Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol. 1993;129(6):708–12.PubMedCrossRefGoogle Scholar
  151. 151.
    Calzavara-Pinton P, Zane C, Rossi M, Sala R, Venturini M. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria. J Am Acad Dermatol. 2012;67(1):e5–9.PubMedCrossRefGoogle Scholar
  152. 152.
    Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):208–13.PubMedCrossRefGoogle Scholar
  153. 153.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):22–31.PubMedCrossRefGoogle Scholar
  154. 154.
    Budiyanto A, Ueda M, Ueda T, Ichihashi M. Formation of cyclobutane pyrimidine dimers and 8-oxo-7,8-dihydro-2′-deoxyguanosine in mouse and organ-cultured human skin by irradiation with broadband or with narrowband UVB. Photochem Photobiol. 2002;76(4):397–400.PubMedCrossRefGoogle Scholar
  155. 155.
    Tzung TY, Runger TM. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol. 1998;67(6):647–50.PubMedCrossRefGoogle Scholar
  156. 156.
    Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol. 1991;71(3):245–8.PubMedGoogle Scholar
  157. 157.
    Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed. 1994;10(5):192–7.PubMedGoogle Scholar
  158. 158.
    Gibbs NK, Traynor NJ, MacKie RM, Campbell I, Johnson BE, et al. The phototumorigenic potential of broad-band (270–350 nm) and narrow-band (311–313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol. 1995;104(3):359–63.PubMedCrossRefGoogle Scholar
  159. 159.
    Tjioe M, Smits T, van de Kerkhof PC, Gerritsen MJ. The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol. 2003;12(6):729–33.PubMedCrossRefGoogle Scholar
  160. 160.
    Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol. 2004;84(5):370–4.PubMedCrossRefGoogle Scholar
  161. 161.
    Black RJ, Gavin AT. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol. 2006;154(3):566–7.PubMedCrossRefGoogle Scholar
  162. 162.
    Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol. 2005;152(4):755–7.PubMedCrossRefGoogle Scholar
  163. 163.
    Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159(4):931–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Westmead HospitalWestmeadAustralia
  2. 2.Department of DermatologyRoyal North Shore HospitalSt LeonardsAustralia
  3. 3.Northern Clinical SchoolThe University of SydneySydneyAustralia

Personalised recommendations